SIK2 and colorectal carcinoma: Furthermore, inhibition of SIK2 with the small molecule ARN‐323612, 13, 14 significantly enhances CRC radiosensitivity by arresting HR‐mediated DNA repair, suggesting a potential therapeutic strategy for overcoming radioresistance in CRC.